| Aug 6 |
MacroGenics: Q2 Earnings Snapshot
|
| Aug 6 |
MacroGenics Provides Update on Corporate Progress, Second Quarter 2024 Financial Results
|
| Aug 1 |
Analysts Just Made A Notable Upgrade To Their MacroGenics, Inc. (NASDAQ:MGNX) Forecasts
|
| Jul 31 |
MacroGenics crashes as trial update leads to downgrades
|
| Jul 31 |
Pinterest Issues Weak Revenue Forecast, Joins Groupon, O-I Glass And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
|
| Jul 31 |
Why AMD Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
|
| Jul 30 |
MacroGenics Provides Vobramitamab Duocarmazine Update
|
| Jul 30 |
MacroGenics Announces Achievement of $100 Million in Milestones Related to Retifanlimab Collaboration with Incyte
|
| Jul 7 |
MacroGenics Insider Ups Holding By 83% During Year
|
| May 25 |
3 Biotech Stocks That Could Be Millionaire-Makers: May Edition
|
